DalsnaFinance Account

Cooper Companies (The) $COO

Health Care · Health Care Supplies · NYSE/NASDAQ

S&P 500 Russell 1000 California

Create a scorecard

$58.76

+0.60 (+1.03%)

As of Oct 20, 2026, 12:59 PM EDT

Price history

Loading chart…

Today's analyst average Analyst average over timeIndividual analyst targets Analyst history starts Oct 15, 2026, the first target we tracked for COO.

Key facts

52-week range (closes): $53.27 – $84.32 Lowest close Sep 15, 2026, highest Jan 6, 2026; 251 daily closes to Oct 13, 2026 from Dalsna Finance's price archive
Fiscal year ends: October Fiscal 2025 ended Oct 31, 2025, from SEC filings
In the S&P 500 since: Sep 22, 2016, replacing Starwood Hotels and Resorts (HOT) · MAR acquired Starwood Hotels · All S&P 500 changes
Analyst coverage: 1 open price target from 1 firm: Piper Sandler Approved targets tracked here; see the analyst section below

Cooper Companies (The) (COO) is trading up at $58.76 (+1.03%) on NYSE/NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Health Care sector.

Analyst price targets on COO

One firm's current price target on Cooper Companies (The): $59 — 0% above the current $58.8. Each is tracked to its date and scored the same way a member's call is.

Piper Sandler $56.6 → $59 by Oct 2027 Neutral Oct 15, 2026 via Investing.com · Piper Sandler's track record

Targets published by research firms, extracted from the news, checked against independent reporting, and linked to their source. Where a firm did not state a horizon the target is tracked as 12 months, the industry convention; the rows where the firm set its own horizon are marked. Reported here as facts about what was published — not recommendations from Dalsna Finance, and no firm listed is affiliated with this site.

Cooper Companies (The) revenue & net income history (FY2016–FY2025)

RevenueNet incomeNet margin (right axis, %)

Cooper Companies (The) annual financial statements
	FY2016Oct 2016	FY2017Oct 2017	FY2018Oct 2018	FY2019Oct 2019	FY2020Oct 2020	FY2021Oct 2021	FY2022Oct 2022	FY2023Oct 2023	FY2024Oct 2024	FY2025Oct 2025
Income statement
Revenue	$1.97B	$2.14B	$2.53B	$2.65B	$2.43B	$2.92B	$3.31B	$3.59B	$3.90B	$4.09B
Growth (year over year)	+9.4%	+8.8%	+18.4%	+4.8%	−8.4%	+20.2%	+13.2%	+8.6%	+8.4%	+5.1%
Gross profit	$1.17B	$1.37B	$1.63B	$1.76B	$1.53B	$1.96B	$2.14B	$2.36B	$2.60B	$2.68B
Gross margin	59.6%	63.9%	64.4%	66.2%	63.1%	66.9%	64.7%	65.6%	66.6%	65.5%
Operating income	$324.1M	$429.1M	$403.1M	$546.7M	$311.8M	$505.8M	$507.6M	$533.1M	$705.7M	$682.9M
Operating margin	16.5%	20.1%	15.9%	20.6%	12.8%	17.3%	15.3%	14.8%	18.1%	16.7%
Net income	$273.9M	$372.9M	$139.9M	$466.7M	$238.4M	$2.94B	$385.8M	$294.2M	$392.3M	$374.9M
Net margin	13.9%	17.4%	5.5%	17.6%	9.8%	100.8%	11.7%	8.2%	10.1%	9.2%
EPS (diluted)	$1.40	$1.88	$0.70	$2.33	$1.20	$14.79	$1.94	$1.48	$1.96	$1.87
Balance sheet
Cash and equivalents	$100.8M	$88.8M	$77.7M	$89.0M	$115.9M	$95.9M	$138.2M	$120.8M	$107.6M	$110.6M
Total assets	$4.48B	$4.86B	$6.11B	$6.27B	$6.74B	$9.61B	$11.5B	$11.7B	$12.3B	$12.4B
Total liabilities	$1.78B	$1.68B	$2.81B	$2.65B	$2.91B	$2.66B	$4.32B	$4.11B	$4.23B	$4.16B
Long-term debt	$1.11B	$1.15B	$1.99B	$1.26B	$1.38B	$1.40B	$2.35B	$2.52B	$2.55B	$2.46B
Shareholders' equity	$2.70B	$3.18B	$3.31B	$3.63B	$3.82B	$6.94B	$7.17B	$7.55B	$8.08B	$8.24B
Cash flow
Operating cash flow	$509.6M	$593.6M	$668.9M	$713.2M	$486.6M	$738.6M	$692.4M	$607.5M	$709.3M	$796.1M
Capital expenditure	$152.6M	$127.2M	$193.6M	$292.1M	$310.4M	$214.4M	$242.0M	$392.5M	$421.2M	$362.4M
Free cash flow	$357.0M	$466.4M	$475.3M	$421.1M	$176.2M	$524.2M	$450.4M	$215.0M	$288.1M	$433.7M
Dividends paid	$2.90M	$2.90M	$2.90M	$3.00M	$3.00M	$3.00M	$3.00M	$3.00M	$0	$0
Share buybacks	$0	$55.0M	$0	$156.1M	$47.8M	$24.8M	$78.5M	$0	$0	$290.1M

RevenueNet incomeNet margin (right axis, %)

Cooper Companies (The) quarterly financial statements
	Q4 FY24^†Oct 2024	Q1 FY25Jan 2025	Q2 FY25Apr 2025	Q3 FY25Jul 2025	Q4 FY25^†Oct 2025	Q1 FY26Jan 2026	Q2 FY26Apr 2026	Q3 FY26Jul 2026
Income statement
Revenue	$1.02B	$964.7M	$1.00B	$1.06B	$1.07B	$1.02B	$1.08B	$1.07B
Growth (year over year)	+9.8%	+3.6%	+6.3%	+5.7%	+4.6%	+6.2%	+7.9%	+0.6%
Gross profit	$677.7M	$660.2M	$679.1M	$692.0M	$650.8M	$695.2M	$735.4M	$711.9M
Gross margin	66.5%	68.4%	67.8%	65.3%	61.1%	67.9%	68.0%	66.8%
Operating income	$198.4M	$182.0M	$184.8M	$175.7M	$140.4M	$212.8M	−$31.0M	$222.0M
Operating margin	19.5%	18.9%	18.4%	16.6%	13.2%	20.8%	−2.9%	20.8%
Net income	$117.5M	$104.3M	$87.7M	$98.3M	$84.6M	$130.8M	−$77.9M	$432.8M
Net margin	11.5%	10.8%	8.7%	9.3%	7.9%	12.8%	−7.2%	40.6%
EPS (diluted)	$0.59	$0.52	$0.44	$0.49	$0.42	$0.66	−$0.40	$2.24
Balance sheet
Cash and equivalents	$107.6M	$100.9M	$116.2M	$124.9M	$110.6M	$124.9M	$138.8M	$154.7M
Total assets	$12.3B	$12.2B	$12.4B	$12.4B	$12.4B	$12.4B	$12.5B	$12.7B
Total liabilities	$4.23B	$4.09B	$4.13B	$4.02B	$4.16B	$4.06B	$4.24B	$4.34B
Long-term debt	$2.55B	$2.49B	$2.52B	$2.43B	$2.46B	$1.88B	$1.86B	$1.91B
Shareholders' equity	$8.08B	$8.13B	$8.29B	$8.35B	$8.24B	$8.36B	$8.24B	$8.33B
Cash flow
Operating cash flow	$268.1M	$190.6M	$96.2M	$261.4M	$247.9M	$260.9M	$182.8M	$341.7M
Capital expenditure	$140.0M	$89.4M	$78.1M	$96.9M	$98.0M	$102.2M	$86.4M	$68.7M
Free cash flow	$128.1M	$101.2M	$18.1M	$164.5M	$149.9M	$158.7M	$96.4M	$273.0M
Dividends paid	$0	—	—	—	—	—	—	—
Share buybacks	$0	$0	$40.6M	$52.7M	$196.8M	$92.5M	$15.5M	$339.2M

From Cooper Companies (The)'s 10-K and 10-Q filings with the SEC; its fiscal year ends in October. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →

Cooper Companies (The) vs the Health Care sector and the S&P 500

Cooper Companies (The)'s latest reported figures next to the median of the other 59 S&P 500 Health Care companies and of the other 502 S&P 500 companies; each median is taken over the companies with a comparable figure (counts in the footnote). A median is the middle value, not an average, so one very large company does not move it.

Cooper Companies (The) compared with the median Health Care company and the median S&P 500 company
Measure	Cooper Companies (The)	Health Care (59 other S&P 500 companies)	S&P 500 (502 other companies)
Revenue growth, latest fiscal year	+5.1%	+7.2%	+7.0%
Net margin, latest fiscal year	9.2%	13.1%	13.0%
Share price change, 1 year	−22.4%	+19.8%	+5.9%

Cooper Companies (The): fiscal year ended October 2025, from its 10-K and 10-Q filings with the SEC. Medians computed October 20, 2026 from each company's latest annual filing (fiscal years ending between July 2025 and September 2026) and our price archive. Prices for every company, Cooper Companies (The) included, are the last regular-session prices of October 19, 2026; the 1-year change compares that price with each company's last close on or before October 20, 2025. Net margin and price change are our calculations from reported figures. Each median counts only the companies with a comparable figure (sector / S&P 500): revenue growth 59/496, net margin 59/496, 1-year price change 59/490; the reasons below can overlap. 12 are left out of the price figure because our archive holds no comparable close for them. The S&P 500 price figure is the middle company's change, not the index's return.